OSM Industry Intel • Spring 2026 The Phospholipid Shift: Why Your Liposomal “Carrier” Is Now Your Second Active Ingredient New market data shows phosphatidylcholine is being repositioned from delivery material to functional co-active. Here is what that means for pricing, positioning, and your next product label. If you manufacture or sell a liposomal supplement, you […]
Learn More
OSM Industry Intel • Spring 2026 Liposomal Delivery for Skin Repair: What New Wound Healing Research Means for Topical Supplement Brands A major 2026 review maps the clinical progress of liposome-based delivery systems for skin wound healing. Here is why topical supplement brands should be paying close attention. Most topical supplements share a fundamental problem. […]
Learn More
OSM Industry Intel • Spring 2026 What Separates a Good Supplement Manufacturer From a Great One in 2026 The U.S. dietary supplement market is projected to exceed $85 billion this year. Here is what brands should actually expect from a manufacturing partner built for the next phase of growth. The supplement industry is in an […]
Learn More
OSM Industry Intel • Spring 2026 Liposomal Technology: How It Works, Why It Matters, and Where Your Next Product Line Fits In Liposomal delivery is reshaping how consumers think about supplement absorption. Here is a practical breakdown of the science, the market opportunity, and the formats worth building around. Here is the uncomfortable truth about […]
Learn More
OSM Industry Intel • Spring 2026 Vitamins B3 and B6 Just Got a Lot More Interesting for Muscle Recovery Supplements A new clinical trial shows nicotinamide plus pyridoxine can accelerate muscle stem cell activity and fiber regeneration after intense exercise. Here is what that means for your next product line. For years, the B-vitamin conversation […]
Learn More